[144] Bridgewater Bancshares, Inc. SEC Filing

Rhea-AI Filing Summary

Bridgewater Bancshares filed a Form 144 reporting a proposed sale of 40,000 shares of Common stock with an aggregate market value of $649,200, to be sold approximately on 08/14/2025 on NASDAQ through broker D.A. Davidson & Co. The filing lists 27,482,534 shares outstanding. Acquisition details show two stock option exercises paid in cash: 25,000 shares acquired on 12/28/2022 and 25,000 on 06/22/2023. The filer reports "Nothing to Report" for securities sold in the past three months and affirms no undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Routine Form 144 reporting a proposed sale of 40,000 shares valued at $649,200; appears procedural, not material.

The filing documents a planned sale through D.A. Davidson of 40,000 common shares with an aggregate market value of $649,200, and notes total outstanding shares of 27,482,534. Acquisition history lists two cash option exercises in 2022 and 2023 totaling 50,000 shares acquired; the sale amount is 40,000. No securities were reported sold in the prior three months. From a market-impact perspective, the notice reads as a standard insider sale filing and does not itself disclose operational or financial changes at the issuer.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing an insider intends to sell shares and affirming no undisclosed material information.

The form includes the attestation that the filer does not possess material non-public information and references the procedural statement about trading plans and Rule 10b5-1. The brokerage details and acquisition dates are documented, and the filer reports no recent sales in the past three months. This filing aligns with standard disclosure and insider-sale compliance practices rather than signaling governance concerns or material corporate events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	D.A. Davidson & Co Two Centerpointe Dr Suite 200 Lake Oswego OR 97035	40000	649200.00	27482534	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/28/2022	Cash Stock Option Exercise	Issuer			25000	12/28/2022	Cash
Common	06/22/2023	Cash Stock Option Exercise	Issuer			25000	06/22/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BWBBP Form 144 report?

The filing reports a proposed sale of 40,000 common shares of Bridgewater Bancshares (BWBBP) valued at $649,200, to be sold on 08/14/2025 on NASDAQ through D.A. Davidson & Co.

How many shares of BWBBP are outstanding according to the filing?

The filing lists 27,482,534 shares outstanding.

When and how were the shares being sold originally acquired?

The acquisition entries show two cash stock option exercises: 25,000 shares on 12/28/2022 and 25,000 shares on 06/22/2023, paid in cash.

Were any BWBBP securities sold by the filer in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed sale in the BWBBP Form 144?

The broker named in the filing is D.A. Davidson & Co (Two Centerpointe Dr Suite 200, Lake Oswego, OR 97035).